Inverse Agonist Actions of Typical and Atypical Antipsychotic Drugs at the Human 5-Hydroxytryptamine2C Receptor | Journal of...
1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (Wash DC) ... 1992) Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 260: ... 1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature (Lond) ... 1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J ...http://jpet.aspetjournals.org/content/299/1/83.long
Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson's disease patients previously reliant on...
The neural mechanisms underlying Parkinson's disease involve overactivity of the STN.19-,21 Levodopa and dopamine receptor ... respond to reduction of antiparkinsonian medication and required additional treatment with the atypical anti psychotic agent, ... Six patients were also using levodopa and oral dopamine receptor agonists (table 1⇓). The mean (SD) total daily levodopa " ... The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J ...http://jnnp.bmj.com/content/74/2/170
Rosiglitazone Treatment Restores Renal Dopamine Receptor Function in Obese Zucker Rats | Hypertension
... insulin-lowering agents. It is likely that as is the case of changes in D1 receptors, there may exist differences in ... Effect of Dopamine on Na,K-ATPase Activity in Proximal Tubules. Dopamine produced a concentration-dependent (1 nmol/L to 1 μmol ... The inhibition of Na,K-ATPase activity by dopamine was absent in obese control rats, but the inhibitory action of dopamine on ... Dopamine, endogenously produced or exogenously infused, activates tubular D1 dopamine receptors, leading to the inhibition of ...http://hyper.ahajournals.org/content/40/6/880
Dopamine Receptor D1 | definition of Dopamine Receptor D1 by Medical dictionary
What is Dopamine Receptor D1? Meaning of Dopamine Receptor D1 medical term. What does Dopamine Receptor D1 mean? ... Looking for online definition of Dopamine Receptor D1 in the Medical Dictionary? Dopamine Receptor D1 explanation free. ... dopamine-regulating drugs. *dopamine-specific sulfotransferase. *dopaminergic. *dopaminergic. *Dopaminergic agent. * ... A gene on chromosome 5q35.1 that encodes G protein-coupled dopamine receptor D1, which is the most abundant dopamine receptor ...http://medical-dictionary.thefreedictionary.com/Dopamine+Receptor+D1
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed...
Cariostatic Agents. Protective Agents. Physiological Effects of Drugs. Dopamine Agents. Neurotransmitter Agents. Molecular ... or dopamine agonist medication or less than 6 half-lives from discontinuance of dopamine agonists) ...https://clinicaltrials.gov/ct2/show/NCT01165632?cond=%22Pilocytic+astrocytoma%22&rank=5
Terlipressin in Septic Shock in Cirrhosis - Full Text View - ClinicalTrials.gov
Dopamine. Norepinephrine. Dopamine Agents. Terlipressin. Lypressin. Adrenergic Agents. Cardiotonic Agents. Sympathomimetics. ... Autonomic Agents. Peripheral Nervous System Agents. Physiological Effects of Drugs. Neurotransmitter Agents. Molecular ... Protective Agents. Adrenergic alpha-Agonists. Adrenergic Agonists. Vasoconstrictor Agents. Antihypertensive Agents. Hemostatics ... Alpha adrenergic drugs (noradrenaline and/or dopamine in continuous infusion). Drug: alpha adrenergic drugs Dopamine (1-20 µg/ ...https://clinicaltrials.gov/ct2/show/NCT00628160
Walking Study for Stroke Rehabilitation - Full Text View - ClinicalTrials.gov
Autonomic Agents. Peripheral Nervous System Agents. Dopamine Agents. Neurotransmitter Agents. Molecular Mechanisms of ... Adrenergic Agents. Adrenergic Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Dopamine ...https://clinicaltrials.gov/ct2/show/NCT00428480?term=SIRROWS&rank=1
Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular...
Peripheral Nervous System Agents. Antidepressive Agents, Second-Generation. Antidepressive Agents. Psychotropic Drugs. Dopamine ... Dopamine Agents. Neurotransmitter Agents. Cytochrome P-450 CYP2D6 Inhibitors. Cytochrome P-450 Enzyme Inhibitors. Enzyme ...https://clinicaltrials.gov/show/NCT01764386
A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of...
Dopamine Agents. Neurotransmitter Agents. Cardiotonic Agents. Sympathomimetics. Autonomic Agents. Peripheral Nervous System ... Dopamine. Central Nervous System Stimulants. Physiological Effects of Drugs. Dopamine Uptake Inhibitors. Neurotransmitter ... Drug Information available for: Dopamine Dopamine hydrochloride Methylphenidate Methylphenidate hydrochloride U.S. FDA ... Exposure to dopamine receptor antagonists within the previous three (3) months.. *Exposure to radiopharmaceuticals within four ...https://clinicaltrials.gov/ct2/show/NCT00301639
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental...
Antiparkinson Agents. Anti-Dyskinesia Agents. Dopamine Agents. Neurotransmitter Agents. Molecular Mechanisms of Pharmacological ...https://clinicaltrials.gov/ct2/show/NCT01592786?term=Asperger+Syndrome&rank=5
Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving - Full...
Autonomic Agents. Peripheral Nervous System Agents. Dopamine Agents. Neurotransmitter Agents. Molecular Mechanisms of ... Adrenergic Agents. Adrenergic Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Dopamine ...https://clinicaltrials.gov/ct2/show/NCT01685463?recr=Open&cond=%22Methamphetamine%22&rank=10
Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder - Full Text View - ClinicalTrials.gov
Dopamine Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Molecular Mechanisms of ... Subjects with well-controlled mild or moderate hypertension on a single antihypertensive agent are allowed. ...https://clinicaltrials.gov/ct2/show/NCT00877487
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) - Full Text View -...
Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Dopamine Antagonists. Dopamine Agents. ... Serotonin Agents. Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Physiological Effects of Drugs. ...https://clinicaltrials.gov/ct2/show/NCT01172652?term=anxiety&rank=5
Intensive Motivational Interviewing for Methamphetamine Dependence - Full Text View - ClinicalTrials.gov
Autonomic Agents. Peripheral Nervous System Agents. Dopamine Agents. Neurotransmitter Agents. Molecular Mechanisms of ... Adrenergic Agents. Adrenergic Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Dopamine ...https://clinicaltrials.gov/ct2/show/NCT01071356?recr=Open&cond=%22Methamphetamine%22&rank=17
An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention...
Dopamine Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Molecular Mechanisms of ...https://clinicaltrials.gov/show/NCT00249353
Bruxism - Wikipedia
... dopamine agents, antidepressants, muscle relaxants, and others. However, there is little, if any, evidence for their respective ... Examples may include dopamine agonists, dopamine antagonists, tricyclic antidepressants, selective serotonin reuptake ... Nicotine stimulates release of dopamine, which is postulated to explain why bruxism is twice as common in smokers compared to ... Evidence for this comes from observations of the modifying effect of medications which alter dopamine release on bruxing ...https://en.wikipedia.org/wiki/Bruxism
Extrapyramidal symptoms - Wikipedia
Another common course of treatment includes dopamine agonist agents such as pramipexole. These medications reverse the symptoms ... Extrapyramidal symptoms are most commonly caused by typical antipsychotic drugs that antagonize dopamine D2 receptors. The most ... Commonly used medications for EPS are anticholinergic agents such as benztropine (Cogentin), diphenhydramine (Benadryl), and ... and norepinephrine-dopamine reuptake inhibitors (NDRI) have also resulted in EPS. Specifically, duloxetine, sertraline, ...https://en.wikipedia.org/wiki/Extrapyramidal_symptoms
6-APB - Wikipedia
... it is a serotonin-norepinephrine-dopamine releasing agent (SNDRA). In addition to actions at the monoamine transporters, 6-APB ... In addition, 6-APB not only blocks the reuptake of these monoamine neurotransmitters but is also a releasing agent of them; ... 6-APB and its structural isomer 5-APB have been tested with a series of agents including: Marquis, Liebermann, Mecke, and ... 6-APB is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) with Ki values of 117, 150, and 2698 nM for the ...https://en.wikipedia.org/wiki/6-APB
List of antidepressants - Wikipedia
... serotonin-norepinephrine-dopamine releasing agent (SNDRA), and weak RIMA Etryptamine [α-Ethyltryptamine (αET)] (Monase) - non- ... may act as a norepinephrine-dopamine releasing agent (NDRA) alternatively or additionally; also a non-competitive antagonist of ... Rampello, Liborio; Nicoletti, Ferdinando; Nicoletti, Francesco (2000). "Dopamine and Depression". CNS Drugs. 13 (1): 35-45. doi ... weak serotonin-dopamine reuptake inhibitor (SDRI) and 5-HT2A and 5-HT2C receptor antagonist Oxaflozane (Conflictan) - 5-HT1A, 5 ...https://en.wikipedia.org/wiki/List_of_antidepressants
Ocotea cymbarum - Wikipedia
Pharmacologically, MDMA acts as a serotonin-norepinephrine-dopamine releasing agent and reuptake inhibitor. ...https://en.wikipedia.org/wiki/Ocotea_cymbarum
3,4-Methylenedioxy-N-ethylamphetamine - Wikipedia
MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor. Possession of MDEA is illegal in ...https://en.wikipedia.org/wiki/3,4-Methylenedioxy-N-ethylamphetamine
Norepinephrine-dopamine reuptake inhibitor - Wikipedia
A closely related type of drug is a norepinephrine-dopamine releasing agent (NDRA). Norepinephrine-dopamine reuptake inhibitors ... A norepinephrine-dopamine reuptake inhibitor (NDRI) is a drug that acts as a reuptake inhibitor for the neurotransmitters ... Monoamine reuptake inhibitor Dopamine reuptake inhibitor Norepinephrine reuptake inhibitor Stephen M. Stahl (2 March 2009). ... This in turn leads to increased extracellular concentrations of both norepinephrine and dopamine and, therefore, an increase in ...https://en.wikipedia.org/wiki/Norepinephrine%E2%80%93dopamine_reuptake_inhibitor
Cathine - Wikipedia
Like amphetamines, cathinone, and ephedrine, cathine acts as a norepinephrine releasing agent (NRA). It also acts as a dopamine ... releasing agent (DRA) to a lesser extent. Cathine is one of the four stereoisomers of phenylpropanolamine (PPA). The World Anti ...https://en.wikipedia.org/wiki/Cathine
List of MeSH codes (D16) - Wikipedia
... dopamine agents MeSH D27.505.519.625.150.151 --- dopamine agonists MeSH D27.505.519.625.150.175 --- dopamine antagonists MeSH ... dopamine agents MeSH D27.505.696.577.150.151 --- dopamine agonists MeSH D27.505.696.577.150.175 --- dopamine antagonists MeSH ... anti-allergic agents MeSH D27.505.954.122 --- anti-infective agents MeSH D27.505.954.122.085 --- anti-bacterial agents MeSH ... antiviral agents MeSH D27.505.954.122.388.077 --- anti-retroviral agents MeSH D27.505.954.122.388.077.088 --- anti-hiv agents ...https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D16)
Spasmodic torticollis - Wikipedia
In the past, dopamine blocking agents have been used in the treatment of spasmodic torticollis. Treatment was based on the ... It has also been suggested that the functional imbalance is due to an imbalance of neurotransmitters such as dopamine, ... Relief from spasmodic torticollis is higher in those patients who take anticholinergic agents when compared to other oral ... of patients who use anticholinergic agents report relief, 21% of patients report relief from clonazepam, 11% of patients report ...https://en.wikipedia.org/wiki/Spasmodic_torticollis